Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Borgert

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Archives of Toxicology|August 12, 2023
Issue analysis: key characteristics approach for identifying endocrine disruptorsChristopher J Borgert
Regulatory Toxicology and Pharmacology : RTP|June 14, 2005
EPA's new guidance for assessing cancer risks from early life exposures: genotoxic mode of action and implications for human health-based standardsChristopher J Borgert
Environmental Science & Technology|March 3, 2007
Conflict of interest: kill the messenger or follow the data?Christopher J Borgert
Regulatory Toxicology and Pharmacology : RTP|November 16, 2005
Understanding human biomonitoringChristopher J Borgert
Critical Reviews in Toxicology|May 22, 2023
Hypothesis-driven weight of evidence evaluation indicates styrene lacks endocrine disruption potentialChristopher J Borgert
Toxicology and Applied Pharmacology|February 20, 2007
Predicting interactions from mechanistic information: can omic data validate theories?Christopher J Borgert
Regulatory Toxicology and Pharmacology : RTP|March 3, 2007
Conflict of interest or contravention of science?Christopher J Borgert
Archives of Gynecology and Obstetrics|August 13, 2022
Lack of evidence associating octamethylcyclotetrasiloxane (D4) with placenta accreta syndromeChristopher J Borgert
EXCLI Journal|May 16, 2025
Hypothesis-driven weight of evidence evaluation indicates ethylbenzene lacks endocrine disruption potential by EATS pathwaysChristopher J Borgert
Archives of Toxicology|February 20, 2025
Octamethylcyclotetrasiloxane (D4) lacks endocrine disruptive potential via estrogen pathwaysChristopher J Borgert, Lyle D Burgoon
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Archives of Toxicology|August 12, 2023
Issue analysis: key characteristics approach for identifying endocrine disruptorsChristopher J Borgert
Regulatory Toxicology and Pharmacology : RTP|June 14, 2005
EPA's new guidance for assessing cancer risks from early life exposures: genotoxic mode of action and implications for human health-based standardsChristopher J Borgert
Environmental Science & Technology|March 3, 2007
Conflict of interest: kill the messenger or follow the data?Christopher J Borgert
Regulatory Toxicology and Pharmacology : RTP|November 16, 2005
Understanding human biomonitoringChristopher J Borgert
Critical Reviews in Toxicology|May 22, 2023
Hypothesis-driven weight of evidence evaluation indicates styrene lacks endocrine disruption potentialChristopher J Borgert
Toxicology and Applied Pharmacology|February 20, 2007
Predicting interactions from mechanistic information: can omic data validate theories?Christopher J Borgert
Regulatory Toxicology and Pharmacology : RTP|March 3, 2007
Conflict of interest or contravention of science?Christopher J Borgert
Archives of Gynecology and Obstetrics|August 13, 2022
Lack of evidence associating octamethylcyclotetrasiloxane (D4) with placenta accreta syndromeChristopher J Borgert
EXCLI Journal|May 16, 2025
Hypothesis-driven weight of evidence evaluation indicates ethylbenzene lacks endocrine disruption potential by EATS pathwaysChristopher J Borgert
Archives of Toxicology|February 20, 2025
Octamethylcyclotetrasiloxane (D4) lacks endocrine disruptive potential via estrogen pathwaysChristopher J Borgert, Lyle D Burgoon
Pageof 6